Israel’s Opaganib Covid pill may be potent against Omicron
Studies on Opaganib have shown an apparent clinical benefit in reducing mortality, getting patients back onto room air and getting them out of the hospital faster…reports Asian Lite News Israel-based RedHill Biopharma